Magnesium sulphate and (123)I-MIBG in pheochromocytoma: Two useful techniques for a complicated disease

M Vendrell1, N Martín1, A Tejedor1

  • 1Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Hospital Clínic Barcelona, Spain.

Insights

Pheochromocytoma can cause severe heart damage, leading to cardiogenic shock. Magnesium sulfate aided cardiovascular stabilization in a patient with pheochromocytoma-induced myocarditis, enabling surgical preparation.

Area of Science:

  • Cardiology
  • Endocrinology
  • Oncology

Background:

  • Pheochromocytoma, a neuroendocrine tumor, can cause significant cardiovascular complications due to excessive catecholamine release.
  • Myocardial damage from pheochromocytoma can manifest as myocarditis, leading to heart failure and cardiogenic shock.

Observation:

  • A 48-year-old female patient with hypertension and diabetes presented with pheochromocytoma-induced myocarditis, resulting in severe cardiogenic shock and a 20% ejection fraction.
  • The patient experienced extreme blood pressure fluctuations requiring aggressive management with vasoactive drugs and an intra-aortic balloon pump.

Findings:

  • Cardiovascular stabilization was achieved with magnesium sulfate, allowing for weaning from vasoactive medications prior to surgical intervention.
  • (123)I-metaiodobenzylguanidine scintigraphy was crucial for confirming tumor tissue and assessing cardiac failure severity and prognosis.

Implications:

  • This case highlights the critical role of magnesium sulfate in managing hemodynamic instability associated with pheochromocytoma-induced myocarditis.
  • Effective management strategies and prognostic tools like (123)I-metaiodobenzylguanidine scintigraphy are essential for improving outcomes in patients with this rare condition.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET